Door-to-needle times for intravenous thrombolytic therapy matter even for ischemic stroke patients who later undergo thrombectomy, a large cohort study finds.
Hospital transfer for acute ischemic stroke is linked to poorer outcomes, and the AHA’s Target: Stroke initiative has trimmed time to thrombolytic therapy and lowered one-year readmissions. So conclude two new national database analyses.
A large national database study has confirmed that the short-term benefits of swift administration of thrombolytic therapy continue out to at least one year.
One of the first episodes of our “Neuro Pathways” podcast features interventional neurologist Shazam Hussain, MD, on the latest in mechanical thrombectomy and other developments in stroke care.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Practice may not make perfect in healthcare, but it can sure make for greater efficiency and effectiveness. This study of our mobile stroke unit’s evolution over three years is a case in point.
A Cleveland Clinic study presented at the 2018 International Stroke Conference suggests these units may help bypass interhospital transfers for patients requiring thrombectomy.
Findings from the first study to examine the importance of treating in the “golden hour” specifically in the setting of ELVO strokes could reshape thinking around ELVO management.
The answer is yes, according to a new national database analysis, but the differences are limited and fairly focused on promptness of reperfusion therapy.
Something’s going right in acute stroke therapy: Medicare data show that one-year mortality fell 18 percent from 2009 to 2013 in tandem with a 60 percent rise in IV tPA use.